v3.26.1
Consolidated Condensed Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss for the period, including noncontrolling interest $ (450,380,518) $ (4,028,322)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation and amortization 3,199,299 803,955
Share based compensation 3,052,746 956,968
Change in fair value of digital assets 391,090
Intangible assets (FIL) revenue (130,154)
Intangible assets (FIL) cost of revenue 138,070
Accelerated amortization of Intangible assets 1,650,000
Deferred tax liability 89,050
Unrealized (gains) losses on foreign currency exchange 11,122,667 (731,755)
Change in fair value of warrant liability 5,255,450
Change in fair value of convertible notes 470,668,608
Gain on investment in NUAI shares (4,984,130)
Gain on sale of investment in TCDC (65,920,568)
Gain on sale of property and equipment (961,713)
Bad debt expense 76,748
Changes in assets and liabilities:    
Trade and other receivables (26,712,905) 932,259
Customer deposits 143,879,911
Other current assets (95,762,765) (24,689)
Other long-term assets (2,212,252) 9,355
Trade and other payables 24,231,858 (879,313)
Income tax payable 7,803,779
Net cash provided by (used in) operating activities 23,241,180 (1,708,451)
CASH FLOWS FROM INVESTING ACTIVITIES    
Advance payments for property and equipment (310,665,524)
Purchase of certificates of deposit (11,804,654)
Payment for the purchase of property and equipment (12,541,952) (37,343)
Investment in a joint venture (3,136,000)
Cash proceeds from sale of TCDC investment 9,850,000
Proceeds from sale of NUAI Shares 14,984,130
Proceeds from convertible note receivable 50,000,000
Proceeds from sales of digital assets 93,051
Net cash provided by (used in) investing activities (263,314,000) 55,708
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from issuance of common stock 586,858,433
Cash received from convertible note issuance 1,065,636,015
Issuance costs related to capital raise (43,500,602)
Proceeds from exercise of warrants 370
Proceeds from issuance of pre-funded warrants 438,141,548
Payment for lease liabilities (712,210) (284,491)
Repayment of note payable (2,249,124)
Net cash provided by (used in) financing activities 2,044,174,430 (284,491)
Effect of exchange rate changes on cash and cash equivalents (13,826,812) (81,793)
Net cash increase/(decreases) in cash and cash equivalents 1,790,274,798 (2,019,027)
Cash and cash equivalents at beginning of period 71,073,024 4,424,805
Cash and cash equivalents at end of period $ 1,861,347,822 $ 2,405,778